Sanofi Pairs Up With Non-Profit Protas In Quest To Cut Clinical Trial Costs
Executive Summary
The French major has committed up to £5m for non-profit Protas, which aims to facilitate large clinical studies at a fraction of the usual price and form more pharmaceutical collaborations down the line.